Becker's Hospital Review - Cardiology
OCTOBER 2, 2024
One in 4 Americans (24%) will develop heart failure in their lifetime, according to a new report published Sept. 24 in the Journal of Cardiac Failure.
HCPLive
OCTOBER 2, 2024
Compared with other international guidelines, the 2024 World Health Organization HBV guidelines had the highest treatment eligibility rates.
DAIC
OCTOBER 2, 2024
tim.hodson Wed, 10/02/2024 - 11:54 Heart failure is a rapidly growing public health issue that can be difficult to manage on a global scale. But there are tools that exist that can improve outcomes, such as guideline-directed medical therapy (GDMT). New UCLA-led research highlights the important role that these guidelines can play in reducing mortality rates for individuals suffering from heart failure with reduced ejection fraction (HFrEF), a type of heart failure affecting an estimated 29 mill
Med Page Today
OCTOBER 2, 2024
(MedPage Today) -- The novel investigational weight loss agent HU6 had mixed results specifically targeting obesity-related heart failure with preserved ejection fraction (HFpEF), based on the small HuMain-HFpEF trial. After 19 weeks on daily.
Dr. Paddy Barrett
OCTOBER 2, 2024
When it comes to assessing and managing the risk of heart disease, we all know that as a healthcare system, we could do better. The main takeaway from Tuesday’s email was that patients want a proper risk assessment, advanced testing, and a plan. I attempt to meet these requirements for my patients and for those going through the Heart Health Formula.
Med Page Today
OCTOBER 2, 2024
(MedPage Today) -- An association between epilepsy and cardiovascular events (CVEs) in older people was likely largely due to the use of enzyme-inducing antiseizure medications (EIASM), according to a prospective cohort study from Canada. Among.
HCPLive
OCTOBER 2, 2024
This month in review highlights vitamin D supplementation in anemia, the prevalence of iron deficiency in US adults, and the efficacy of rpFVIII in treating acquired hemophilia A.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
CardiacWire
OCTOBER 2, 2024
A new HFpEF treatment might be on the horizon, after results from the EMBARK-HFpEF trial showed that BMS’ hypertrophic cardiomyopathy treatment, mavacamten (Camzyos), safely improved key HFpEF symptoms and biomarkers. Mavacamten is the only cardiac myosin inhibitor with FDA approval to treat obstructive HCM, and works by reducing heart muscle contraction and improving blood flow.
HCPLive
OCTOBER 2, 2024
A recent study found that after 2019, the combined cost of fatal falls among people aged ≥ 45 exceeded firearm injury costs, highlighting the economic burden of senior falls.
Science Daily - Heart Disease
OCTOBER 2, 2024
Researchers have identified a new potential risk marker for cardiovascular disease in women. A new study shows an association between low levels of an anti-inflammatory antibody and the risk of heart attack and coronary heart disease.
Becker's Hospital Review - Cardiology
OCTOBER 2, 2024
Worcester, Mass.-based UMass Chan Medical School has partnered with South Korea-based Hallym University on an AI application to expand healthcare access for rural stroke patients.
Medical Xpress - Cardiology
OCTOBER 2, 2024
Researchers at Karolinska Institutet have identified a new potential risk marker for cardiovascular disease in women. A new study shows an association between low levels of an anti-inflammatory antibody and the risk of heart attack and coronary heart disease.
HCPLive
OCTOBER 2, 2024
An analysis of NYC’s lead registry data from 2005 to 2019 revealed a potential association between sickle cell disease and childhood lead poisoning.
Journal of Cardiothoracic Surgery
OCTOBER 2, 2024
Computed tomography aortography (CTA) is used in the assessment of aortic pathologies and planning of surgical intervention. However, its dependence on iodinated contrast can result in development of contrast-.
HCPLive
OCTOBER 2, 2024
The phase 3b/4 findings from PSORIATYK SCALP suggest that oral deucravacitinib led to significant improvements for patients with scalp psoriasis.
Journal of Cardiothoracic Surgery
OCTOBER 2, 2024
Acute kidney injury (AKI) represents a significant post-cardiac surgery complication, particularly prevalent among individuals with pre-existing renal dysfunction. Chronic kidney disease (CKD) is frequently ac.
HCPLive
OCTOBER 2, 2024
The data also support the validity of further research into targeting CD-40 signaling in patients with RA not responding to treatment.
Journal of Cardiothoracic Surgery
OCTOBER 2, 2024
"Swiss Cheese" ventricular septal defects represent a serious congenital heart disease with suboptimal clinical outcomes and a lack of consensus regarding its management. This study presents mid-term follow-up.
HCPLive
OCTOBER 2, 2024
This segment of Marghoob’s interview featured a discussion of pigmented lesion identification and use of technology such as AI.
Journal of Cardiothoracic Surgery
OCTOBER 2, 2024
To compare the therapeutic effects of right vertical infra-axillary thoracotomy (RVIAT) and Standard Median Sternotomy (SMS) in the repair of atrial septal defect (ASD) and ventricular septal defect (VSD), and.
HCPLive
OCTOBER 2, 2024
Only 6.7% of patients with an abnormal protein dipstick test result had guideline-recommended follow-up albuminuria testing.
American College of Cardiology
OCTOBER 2, 2024
What is the association between late gadolinium enhancement (LGE) on cardiac magnetic resonance imaging (cMRI) and sudden cardiac death (SCD) in pediatric patients with hypertrophic cardiomyopathy (HCM), and does it add to pediatric SCD risk models?
HCPLive
OCTOBER 2, 2024
Rahul Aggarwal, MD, discusses how the VICTORION-1 PREVENT trial eligibility criteria apply to the general US population.
HeartRhythm
OCTOBER 2, 2024
Decades ago, an association of J waves with cardiac arrest (CA) or ventricular fibrillation (VF) was reported (1), whereas J waves have been observed in individuals in the general population. Mechanistically, J waves are thought to be mediated predominantly via increased transient outward currents (Ito) characterized by bradycardia-dependent augmentation (2-3).
HCPLive
OCTOBER 2, 2024
More research is needed to investigate changing trends at presentation and help to inform current treatment strategies.
Hypertension Journal
OCTOBER 2, 2024
Hypertension, Ahead of Print. Hypertension requires increased systemic vascular resistance. Thus far, Mendelian hypertension–related genes are related to salt retention, an indirect regulatory effect. With the identification of mutated, overactive, PDE3A (phosphodiesterase 3A), we have uncovered a more direct vasoconstrictive mechanism. The autosomal-dominant syndrome features another specific phenotype, brachydactyly type E.
HCPLive
OCTOBER 2, 2024
The HCPLive Cardiology month in review for September 2024 spotlights ESC Congress 2024, Family Heart Global Summit, pipeline updates, and more!
American College of Cardiology
OCTOBER 2, 2024
What is the safety and efficacy of sacubitril/valsartan as compared with enalapril in children 1 month to
Medical Xpress - Cardiology
OCTOBER 2, 2024
Heart failure is a rapidly growing public health issue that can be difficult to manage on a global scale. But there are tools that exist that can improve outcomes, such as guideline-directed medical therapy (GDMT).
Journal of Cardiothoracic Surgery
OCTOBER 2, 2024
Despite key differences in pathological processes, both Intramural Hematomas and Aortic Dissections are Acute Aortic Syndromes repaired with similar surgical technique. The objective of this study was to deter.
Stroke Journal
OCTOBER 2, 2024
Stroke, Ahead of Print. BACKGROUND:It is unknown whether hypertensive microangiopathy or cerebral amyloid angiopathy (CAA) predisposes more to anticoagulant-associated intracerebral hemorrhage (AA-ICH). The purpose of our study was to determine whether AA-ICH is associated with lobar location and probable CAA.METHODS:This was a cross-sectional analysis of patients with first-ever spontaneous ICH admitted to a tertiary hospital in Boston, between 2008 and 2023.
American College of Cardiology
OCTOBER 2, 2024
What is the diagnostic yield of screening relatives of hypertrophic cardiomyopathy (HCM) patients and predictive factors for HCM development during long-term follow-up in relatives from gene-elusive families?
DAIC
OCTOBER 2, 2024
tim.hodson Wed, 10/02/2024 - 11:08 Sept. 30, 2024 — Cytokinetics, Inc. recently announced that additional analyses synthesizing data from SEQUOIA-HCM ( S afety, E fficacy, and Q uantitative U nderstanding of O bstruction I mpact of A ficamten in HCM ), the Phase 3 clinical trial of aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM), were presented virtually at the Heart Failure Society of America (HFSA) Annual Scientific Meeting by Martin Maron, M.D.,
Medical Xpress - Cardiology
OCTOBER 2, 2024
Variants in a gene that plays a key role in heart function can cause potentially life-threatening arrhythmia syndromes known as calmodulinopathy.
Dr. S. Venkatesan MD
OCTOBER 2, 2024
One of my colleagues was joking ,nowadays patients force us to read or even educate us. I completely concurred with him. Doctor, do you have any investigation to know how much the total plaque burden is in my coronary artery? Yes. Sure , we have many modalities, right from CT calcium to OCT, NIR, etc. How would I know , which one of them is high risk and vulnerable ?
American College of Cardiology
OCTOBER 2, 2024
In this week’s View, Dr. Eagle looks at sex-specific differences in alive hospital discharge following abdominal aortic aneurysm (AAA) repair.
Expert insights. Personalized for you.
110 
Let's personalize your content